The Medpage Today staff reported this week on a CNN investigation of Nuedexta, a drug approved for PseudoBulbar Affect (PBA). The investigation found PBA is being marketed aggressively to the elderly as a therapy for dementia. Even though independent studies indicate PBA …

Drug Makers Putting Profit Before The Elderly Read more »

As I have written in Health Attitude: Unraveling and Solving the Complexities of Healthcare, there are many problems with the American healthcare system. The number one problem is the high cost. It is not the cost of the insurance, it is …

Congress Puts Drug Lobbyists Ahead of Those They are Supposed to Represent Read more »